Pay in 4 interest-free payments of $6.36 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Accordingly, better control of cardiovascular risk factors such as blood pressure (BP) in patients with T2D is required to achieve favorable cardiovascular safety goals
J Am Coll Nutr 34:175183
Synaptopathy in the noise-exposed and aging cochlea: primary neural degeneration in acquired sensorineural hearing loss
Borderline basal ganglia hemorrhage volume: patient selection for good clinical outcome after stereotactic catheter drainage
The SURMOUNT-5 trial was a Phase 3b, randomized, head-to-head study the gold standard of clinical research design
US$ 26.71
US$ 24.08
US$ 25.25
US$ 23.16
